I agree that this site is using cookies. You can find further informations here.
X
Mayo, Marlyn
151  results:
Search for persons X
?
1

THU-105 Improvement in lipid profiles with elafibranor trea..:

Mayo, Marlyn J. ; Antunes, Nuno ; Pedersen, Mark...
Journal of Hepatology.  80 (2024)  - p. S312-S313 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Relationship between pruritus and sleep in participants wit..:

von Maltzahn, Robyn ; Mayo, Marlyn J. ; Smith, Helen T....
Journal of Patient-Reported Outcomes.  8 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
3

Prognostic scores for ursodeoxycholic acid-treated patients..:

Montano-Loza, Aldo J. ; Lytvyak, Ellina ; Hirschfield, Gideon...
Journal of Hepatology.  , 2024
Link: https://doi.org/10.1016/..
 
?
4

Impact of itch on quality of life in people with primary bi..:

Mayo, Marlyn J. ; Carey, Elizabeth ; Smith, Helen T....
Future Rare Diseases.  4 (2024)  1 - p. , 2024
Link: https://doi.org/10.2217/..
 
?
5

LBP-006 Efficacy of elafibranor in primary biliary cholangi..:

Bowlus, Christopher L. ; Kowdley, Kris V. ; Levy, Cynthia...
Journal of Hepatology.  80 (2024)  - p. S80 , 2024
Link: https://doi.org/10.1016/..
 
?
6

LBP-028 Effect of elafibranor on pruritus in primary biliar..:

Kremer, Andreas E. ; Kowdley, Kris V. ; Levy, Cynthia...
Journal of Hepatology.  80 (2024)  - p. S91-S92 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Loss of biochemical response at any time worsens outcomes i..:

Roberts, Surain B. ; Choi, Woo Jin ; Worobetz, Lawrence...
JHEP Reports.  , 2024
Link: https://doi.org/10.1016/..
 
?
8

LBP-040 Long-term efficacy and safety of open-label seladel..:

Trivedi, Palak J. ; Levy, Cynthia ; Kowdley, Kris V....
Journal of Hepatology.  80 (2024)  - p. S98 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Primary biliary cholangitis drug evaluation and regulatory ..:

Jones, David E.J. ; Beuers, Ulrich ; Bonder, Alan...
Hepatology.  , 2024
Link: https://doi.org/10.1097/..
 
?
10

Seladelpar efficacy and safety at 3 months in patients with..:

Hirschfield, Gideon M. ; Shiffman, Mitchell L. ; Gulamhusein, Aliya...
Hepatology.  78 (2023)  2 - p. 397-415 , 2023
Link: https://doi.org/10.1097/..
 
?
11

Open‐label, clinical trial extension: Two‐year safety and e..:

Mayo, Marlyn J. ; Vierling, John M. ; Bowlus, Christopher L....
Alimentary Pharmacology & Therapeutics.  59 (2023)  2 - p. 186-200 , 2023
Link: https://doi.org/10.1111/..
 
?
12

Correction to: Impact of Pruritus on Quality of Life and Cu..:

Mayo, Marlyn J. ; Carey, Elizabeth ; Smith, Helen T....
Digestive Diseases and Sciences.  68 (2023)  10 - p. 4064-4065 , 2023
Link: https://doi.org/10.1007/..
 
?
13

Editorial: The evolving paradigms and treatments for primar..:

Mayo, Marlyn J. ; Vierling, John M. ; Bowlus, Christopher L.
Alimentary Pharmacology & Therapeutics.  59 (2023)  2 - p. 282-282 , 2023
Link: https://doi.org/10.1111/..
 
?
14

GLIMMER: A Randomized Phase 2b Dose-Ranging Trial of Lineri..:

Levy, Cynthia ; Kendrick, Stuart ; Bowlus, Christopher L....
Clinical Gastroenterology and Hepatology.  21 (2023)  7 - p. 1902-1912.e13 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Seladelpar treatment reduces IL-31 and pruritus in patients..:

Kremer, Andreas E. ; Mayo, Marlyn J. ; Hirschfield, Gideon M....
Hepatology.  80 (2023)  1 - p. 27-37 , 2023
Link: https://doi.org/10.1097/..
 
1-15